Catalyst Wire Dossier Catalyst Wire Dossier

DP-R213

· Alvogen Korea
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for DP-R213, covering 2016-03-11 to 2017-06-05. Get the full timeline:

Most recent: Clinical Trial Update: DP-R213 Phase 1 Pharmacokinetics Study [Phase 1]

See pricing